Skip to main content

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Margarita Navarro Pérez

Margarita Navarro Pérez

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Mohamed Bahij El Hachache Sari

Mohamed Bahij El Hachache Sari

Predoctoral researcher
Infectious Diseases
Read more
Diego Rojo Lazaro

Diego Rojo Lazaro

Research technician
Liver Diseases
Read more
Ángela Sánchez Osuna

Ángela Sánchez Osuna

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Sergio Torres Dominguez

Sergio Torres Dominguez

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.